Dr Nicholas Marston, Brigham and Women’s Hospital, Boston, USA, considers the major milestones reached by novel triglyceride lowering agents in 2025 and looks ahead at clinical trials that are expected to report exciting new data during 2026.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
